Use of GLP-1 medications Source: Montero, et al KFF, November 14, 2025 KFF published survey data showing that one in 12 American adults report that they are currently taking GLP-1 medications
GLP-1SNS GLP-1 GLP-1 GLP-1Glucagon-Like Peptide-1L : : : : GLP-1 23 GLP-1GLP-111 GLP-1 GLP-12 1
Instead of constantly fighting hunger, many patients finally feel in control of their eating for the first time in years
A recent study suggested that plasma levels of 5-MT, a compound related to serotonin metabolism, may be decreased in CFS patients, but this has been interpreted as a confounder caused by serotonin-selective reuptake inhibitor (SSRI) use in these patients ( The principal role of carnitine is to transport long-chain fatty acids into the mitochondria for energy production via beta-oxidation ( While carnitine supplementation could have benefits, some recent studies suggest that chronic oral L-carnitine administration may be associated with an increased risk for atherosclerosis via increased trimethylamine (TMA) and/or trimethylamine N-Oxide (TMAO) levels ( Mitochondrial dysfunction has been suggested to contribute to CFS ( The mechanisms that link carnitine intake, S-5-HT, and fatigue, in both CFS and hypothyroidism, are yet unknown
GLP-1 and GIP receptor agonistsare unlikely to cause severe hypoglycemia unless combined with other medications for diabetes